A microdialysis study of pharmacokinetics of orally or intravenously administrated levofloxacin in lung tissues of the streptococcus pneumoniae pneumonia rat

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 4, 2016, Pages 7247-7255

  Li, Yi ^a   Wang, Zhuo ^b   Xiao, Heping ^c   Ning, Yunye ^b   Zhou, Jai ^b   Liu, Rui ^b   Huang, Yi ^b  

^a No 411 Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI PULMONARY HOSPITAL   (China)

Author keywords

Levofloxacin; Microdialysis; Pharmacodynamics; Pharmacokinetics; Streptococcus pneumoniae pneumonia

Indexed keywords

EID: 84964910743     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Thiem U, Heppner HJ, Pientka L. Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging 2011; 28: 519-537.
2. Pletz MW, Rohde G, Schutte H. Epidemiology and aetiology of community-acquired pneumonia (CAP). Dtsch Med Wochenschr 2011; 136: 775-780.
3. Cilloniz C, Ewig S, Polverino E. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorx 2011; 66: 340-346.
4. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital State Rep 2005; 53: 1-89.
5. Dhanani J, Roberts JA, Chew M, Lipman J, Boots RJ, Paterson DL, Fraser JF. Antimicrobial chemotherapy and lung microdialysis: a review. Int J Antimicrob Agents 2010; 36: 491-500.
6. Marchand S, Dahyot C, Lamarche I, Mimoz O, Couet W. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob. Agents Chemother 2005; 49: 2356-2361.
7. Leandro Tasso, Clarissa C. Bettoni, Laura K. Oliveira, Dalla Costa T. Evaluation of gatifloxacin penetration into skeletal muscle and lung by microdialysis in rats. Int J Pharm 2008; 358: 96-101.
8. Jones RN, Sader HS, Fritsche TR. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimierobial Surveillance Program (1998-2004). Diagn Mierobiol Infect Dis 2007; 57: 109-116.
9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007; 44 Suppl 2: S27-S72.
10. Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 2001; 33 Suppl 3: S147-S156.
11. Cui J, Liu Y, Wang R, Tong W, Drlica K, Zhao X. The mutant selection window in rabbits infected with Staphylococcus aureus. J Infect Dis 2006; 194: 1601-1608.
12. Guo P, Yu J, Zhang J. Mutant prevention concentrations of fluoroquinolones against clinically- isolated Streptococcus pneumonia. Chi nese Journal of Infection and Chemotherapy 2010; 10: 13-16.
13. Hutschala D, Skhirtladze K, Zuckermann A, Wisser W, Jaksch P, Mayer-Helm BX, Burgmann H, Wolner E, Müller M, Tschernko EM. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. AAntimicrob Agents Chemother 2005; 49: 5107-5111.
14. Hutschala D, Kinstnez C, Skhirtladze K, Mayer- Helm BX, Zeitlinger M, Wisser W, Müller M, Tschernko E. The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study. Inten Care Med 2008; 34: 1827-1834.